CAMP4 Therapeutics is focused on leveraging its innovative RAP Platform™ to discover and develop therapies for a wide range of diseases. This platform enables the generation of therapeutic candidates that facilitate specific, tunable, and durable amplification of mRNA. By harnessing the unique properties of RNA, CAMP4 aims to create RNA Actuator therapeutic candidates that can significantly impact patient outcomes, particularly in areas such as metabolic disorders and central nervous system diseases. The company is also exploring applications in skeletal muscle, heart, and immune system conditions, indicating a broad and ambitious approach to therapeutic development.

The core technology behind CAMP4's efforts lies in the ability to restore gene expression through RNA modulation. This approach allows for targeted interventions that can potentially correct or compensate for genetic deficiencies or malfunctions. By focusing on genetically validated targets, CAMP4 is positioned to explore new therapeutic horizons, aiming to provide patients with innovative treatments that enhance their quality of life and address unmet medical needs.

United States

At CAMP4 Therapeutics, we are pioneering a novel approach to programmable therapeutics. We combine a deep understanding of regulatory RNA and gene expression with a complementary and customizable oligonucleotide modality. Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.

Digestive System Diseases

Genetic Diseases

Liver Diseases

Metabolic Diseases

Nervous System Diseases

CAMP4 Therapeutics

Urea cycle disorder

Camp Drug #1

Biologics

Primary biliary cholangitis

Camp Drug #2

Dravet syndrome

Camp Drug #3

Massachusetts

Antisense Oligonucleotides

Artificial Intelligence

Bioinformatics

Gene Editing/CRISPR

Therapeutic

CAMP4 Therapeutics

Company Details